Study of DU-176b Aged 80 Years or Older

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 984 participants.

Also called NCT02801669

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 984 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02801669
Other papers using this trial's data
  • Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial JAMA cardiology, 2022-06-01 DOI, PubMed 35416910, PMC9008564 In the PMC Open Access subset under CC BY-NC-ND.
  • Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial Journal of the American Heart Association, 2024-02-06 DOI, PubMed 38240204, PMC11056111 In the PMC Open Access subset under CC BY.
  • Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub-Analysis of the ELDERCARE-AF Trial Journal of the American Heart Association, 2022-09-06 DOI, PubMed 36056729, PMC9496443 In the PMC Open Access subset under CC BY.
  • Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation The New England journal of medicine, 2020-10-29 DOI, PubMed 32865374

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02801669. Randomized; triple masking; primary purpose prevention. Start 2016-08-05 (actual); primary completion 2019-12-27 (actual). Results posted on 2020-11-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of DU-176b Aged 80 Years or Older
Intervention (Drug)
Du-176b
Intervention (Drug)
placebo
Lead sponsor
Daiichi Sankyo Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02801669
Content hash
cf8b7f7497931850c899c5e64f218fa589fa4aaf40fcccbbc02ca9bbffc4ce0b